Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 2
2004 1
2005 1
2006 4
2007 1
2008 2
2009 2
2010 1
2011 3
2012 2
2013 4
2014 3
2015 4
2016 8
2017 5
2018 7
2019 12
2020 18
2021 20
2022 21
2023 24
2024 23
2025 19
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

178 results

Results by year

Filters applied: . Clear all
Page 1
Longer-term effects of intermittent fasting on body composition and cardiometabolic health in adults with overweight and obesity: A systematic review and meta-analysis.
Khalafi M, Maleki AH, Ehsanifar M, Symonds ME, Rosenkranz SK. Khalafi M, et al. Obes Rev. 2025 Feb;26(2):e13855. doi: 10.1111/obr.13855. Epub 2024 Nov 5. Obes Rev. 2025. PMID: 39501676
Compared with CON, IF significantly reduced body weight [WMD: -2.84 kg], BMI [WMD: -1.41 kg.m(2)], fat mass [WMD: -3.06 kg], fat-free mass [WMD: -0.81 kg], waist circumference [WMD: -3.85 cm], visceral fat [SMD: -0.37], fasting glucose [WMD: -0.14 mmol/l], triglycerides [W …
Compared with CON, IF significantly reduced body weight [WMD: -2.84 kg], BMI [WMD: -1.41 kg.m(2)], fat mass [WMD: -3.06 kg], fat-free …
The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.
Strunz B, Momayyezi P, Bilev E, Muvva JR, Chen P, Bister J, Schaffer M, Akber M, Cornillet M; Karolinska KI/K COVID-19 Study Group; Horowitz A, Malmberg KJ, Rooyackers O, Aleman S, Ljunggren HG, Björkström NK, Strålin K, Hammer Q. Strunz B, et al. Genes Immun. 2025 Feb;26(1):70-74. doi: 10.1038/s41435-024-00302-6. Epub 2024 Nov 1. Genes Immun. 2025. PMID: 39487235 Free PMC article.
We found that HLA-B -21 M/M genotypes were more prevalent in patients with moderate compared to severe COVID-19 (6.0% vs. 0.9%). Comparison of age- and sex-matched sub-groups revealed that patients with M/M genotypes required mechanical respiratory sup …
We found that HLA-B -21 M/M genotypes were more prevalent in patients with moderate compared to severe COVID-19 (6.0% vs. 0.9% …
Measuring the availability of human resources for health and its relationship to universal health coverage for 204 countries and territories from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.
GBD 2019 Human Resources for Health Collaborators. GBD 2019 Human Resources for Health Collaborators. Lancet. 2022 Jun 4;399(10341):2129-2154. doi: 10.1016/S0140-6736(22)00532-3. Epub 2022 May 23. Lancet. 2022. PMID: 35617980 Free PMC article.
RETRACTION: Immunomodulatory effects of nanocurcumin on Th17 cell responses in mild and severe COVID-19 patients.
[No authors listed] [No authors listed] J Cell Physiol. 2024 Nov;239(11):e31356. doi: 10.1002/jcp.31356. Epub 2024 Jul 16. J Cell Physiol. 2024. PMID: 39014938
S. Tahmasebi, M. A. El-Esawi, Z. H. Mahmoud, A. Timoshin, H. Valizadeh, L. Roshangar, M. Varshoch, A. Vaez, S. Aslani, J. G. Navashenaq, L. Aghebati-Maleki, M. Ahmadi, "Immunomodulatory Effects of Nanocurcumin on Th17 Cell Responses in Mild and Severe …
S. Tahmasebi, M. A. El-Esawi, Z. H. Mahmoud, A. Timoshin, H. Valizadeh, L. Roshangar, M. Varshoch, A. Vaez, S. Aslani, J. G. N …
Mapping age- and sex-specific HIV prevalence in adults in sub-Saharan Africa, 2000-2018.
Haeuser E, Serfes AL, Cork MA, Yang M, Abbastabar H, Abhilash ES, Adabi M, Adebayo OM, Adekanmbi V, Adeyinka DA, Afzal S, Ahinkorah BO, Ahmadi K, Ahmed MB, Akalu Y, Akinyemi RO, Akunna CJ, Alahdab F, Alanezi FM, Alanzi TM, Alene KA, Alhassan RK, Alipour V, Almasi-Hashiani A, Alvis-Guzman N, Ameyaw EK, Amini S, Amugsi DA, Ancuceanu R, Anvari D, Appiah SCY, Arabloo J, Aremu O, Asemahagn MA, Jafarabadi MA, Awedew AF, Quintanilla BPA, Ayanore MA, Aynalem YA, Azari S, Azene ZN, Darshan BB, Babalola TK, Baig AA, Banach M, Bärnighausen TW, Bell AW, Bhagavathula AS, Bhardwaj N, Bhardwaj P, Bhattacharyya K, Bijani A, Bitew ZW, Bohlouli S, Bolarinwa OA, Boloor A, Bozicevic I, Butt ZA, Cárdenas R, Carvalho F, Charan J, Chattu VK, Chowdhury MAK, Chu DT, Cowden RG, Dahlawi SMA, Damiani G, Darteh EKM, Darwesh AM, das Neves J, Weaver ND, De Leo D, De Neve JW, Deribe K, Deuba K, Dharmaratne S, Dianatinasab M, Diaz D, Didarloo A, Djalalinia S, Dorostkar F, Dubljanin E, Duko B, El Tantawi M, El-Jaafary SI, Eshrati B, Eskandarieh S, Eyawo O, Ezeonwumelu IJ, Ezzikouri S, Farzadfar F, Fattahi N, Fauk NK, Fernandes E, Filip I, Fischer F, Foigt NA, Foroutan M, Fukumoto T, Gad MM, Gaidhane AM, Gebregiorg… See abstract for full author list ➔ Haeuser E, et al. BMC Med. 2022 Dec 19;20(1):488. doi: 10.1186/s12916-022-02639-z. BMC Med. 2022. PMID: 36529768 Free PMC article.
RETRACTION: Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor.
[No authors listed] [No authors listed] Small. 2024 Sep;20(37):e2406237. doi: 10.1002/smll.202406237. Epub 2024 Aug 12. Small. 2024. PMID: 39132745
R. Taheri-Ledari, W. Zhang, M. Radmanesh, S. S. Mirmohammadi, A. Maleki, N. Cathcart and V. Kitaev, "Multi-Stimuli Nanocomposite Therapeutic: Docetaxel Targeted Delivery and Synergies in Treatment of Human Breast Cancer Tumor," Small 16, no. 41 (2020): 2002733, http …
R. Taheri-Ledari, W. Zhang, M. Radmanesh, S. S. Mirmohammadi, A. Maleki, N. Cathcart and V. Kitaev, "Multi-Stimuli Nanocomposi …
178 results